Focusing on GBM, we next compared the expression of NRF2 gene between tumor samples from the Cancer Genome Atlas (TCGA) and normal brain tissues, and we observed a significant increased expression of NRF2 in tumors (Fig 1B). The gene discussed is NFE2L2; the disease is neoplasm.